No Data
No Data
No Data
No Data
No Data
Immutep Started at Buy by Canaccord Genuity >IMM.AU
Immutep Started at Buy by Canaccord Genuity >IMM.AU
Dow JonesMay 1 06:17
Canaccord Starts Immutep at Buy, Price Target Is AU$1.00
09:02 PM EDT, 04/29/2024 (MT Newswires) -- Canaccord Starts Immutep at Buy, Price Target is AU$1.00 Price (AUD): $0.45, Change: $, Percent Change: %
MT NewswiresApr 30 09:02
Immutep Price Target Raised 23% to A$0.80/Share by Bell Potter
Immutep Price Target Raised 23% to A$0.80/Share by Bell Potter
Dow JonesApr 29 06:38
Immutep Shares Rise 12% After Positive Data From Eftilagimod Trial
By Chris Wack Immutep Limited shares were up 12% at $2.82 after the company said it saw positive preliminary topline results from its Phase IIb trial evaluating eftilagimod alpha, or efti, in combin
WSJApr 24 22:08
Wilsons Sticks to Its Buy Rating for Immutep Ltd (PRRUF)
TipRanksApr 23 13:05
Immutep Taps Center for Human Drug Research for IMP761 Human Clinical Trial
Biotechnology company Immutep (ASX:IMM) entered into an agreement with the Center for Human Drug Research in the Netherlands to perform a first-in-human clinical study of IMP761, a first-in-class immu
MT NewswiresApr 18 12:12
No Data
No Data